Literature DB >> 11130859

Respiratory syncytial virus activity--United States, 1999-2000 season.

.   

Abstract

Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract illness (LRTI) among infants and children worldwide (1) and is an important cause of LRTI among older children and adults (2). Despite the presence of maternal antibodies, most hospitalizations occur among infants aged <6 months, and nearly all children are infected by age 2 years (3). Although primary infection is usually most severe, reinfection throughout life is common (4). In temperate climates, RSV infections occur primarily during annual outbreaks, which peak during winter months (5). In the United States, RSV activity is monitored by the National Respiratory and Enteric Virus Surveillance System (NREVSS), a voluntary, laboratory-based system. This report summarizes trends in RSV activity reported to NREVSS from July 1999 through June 2000 and presents preliminary surveillance data from July 8 through November 21, 2000, which indicate that RSV community outbreaks are becoming widespread.

Entities:  

Mesh:

Year:  2000        PMID: 11130859

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  13 in total

1.  Climatic factors and lower respiratory tract infection due to respiratory syncytial virus in hospitalised infants in northern Spain.

Authors:  Santiago Lapeña; Mariá Belén Robles; Leticia Castañón; Juan Pablo Martínez; Sofiá Reguero; María Paz Alonso; Isabel Fernández
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

2.  Effects of mass media coverage on timing and annual receipt of influenza vaccination among Medicare elderly.

Authors:  Byung-Kwang Yoo; Margaret L Holland; Jay Bhattacharya; Charles E Phelps; Peter G Szilagyi
Journal:  Health Serv Res       Date:  2010-10       Impact factor: 3.402

3.  Performance characteristics of VIDAS and directigen respiratory syncytial virus (RSV) antigen detection assays and culture for the identification of RSV in respiratory specimens.

Authors:  Julie A Ribes; John Pat Seabolt; Sue B Overman
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

4.  Cholesterol-rich microdomains as docking platforms for respiratory syncytial virus in normal human bronchial epithelial cells.

Authors:  Homero San-Juan-Vergara; Viviana Sampayo-Escobar; Niradiz Reyes; Byeong Cha; Lisandro Pacheco-Lugo; Terianne Wong; Mark E Peeples; Peter L Collins; Maria Eugenia Castaño; Shyam S Mohapatra
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

5.  Epidemiology of respiratory syncytial virus in children ≤2 years of age hospitalized with lower respiratory tract infections in the Russian Federation: a prospective, multicenter study.

Authors:  Vladimir Tatochenko; Vasily Uchaikin; Aleksandr Gorelov; Konstantin Gudkov; Andrew Campbell; Gregory Schulz; Rebecca Prahl; Gerard Notario
Journal:  Clin Epidemiol       Date:  2010-10-21       Impact factor: 4.790

6.  Mucosal delivery of a double-stapled RSV peptide prevents nasopulmonary infection.

Authors:  Gregory H Bird; Sandhya Boyapalle; Terianne Wong; Kwadwo Opoku-Nsiah; Raminder Bedi; W Christian Crannell; Alisa F Perry; Huy Nguyen; Viviana Sampayo; Ankita Devareddy; Subhra Mohapatra; Shyam S Mohapatra; Loren D Walensky
Journal:  J Clin Invest       Date:  2014-04-17       Impact factor: 14.808

7.  Comparison of risk factors between preterm and term infants hospitalized for severe respiratory syncytial virus in the Russian Federation.

Authors:  Katherine L Gooch; Gerard F Notario; Gregory Schulz; Konstantin M Gudkov; Katharina Buesch; Hoa Khong; Andrew Campbell
Journal:  Int J Womens Health       Date:  2011-05-06

8.  Respiratory syncytial virus infection: from biology to therapy: a perspective.

Authors:  Shyam S Mohapatra; Richard F Lockey
Journal:  World Allergy Organ J       Date:  2008-02       Impact factor: 4.084

Review 9.  Pathophysiological mechanisms for the respiratory syncytial virus-reactive airway disease link.

Authors:  Giovanni Piedimonte
Journal:  Respir Res       Date:  2002-06-24

Review 10.  Immunoprophylaxis of respiratory syncytial virus: global experience.

Authors:  Eric A F Simoes
Journal:  Respir Res       Date:  2002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.